Community Hub0 Subscribers
Community hub
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub for Cinanserin. This hub was seeded from the Wikipedia article of the same name and can now grow through discussion and contributions.
Knowledge base stats:
0Articles
1Media
0Notes
0Timelines
0Days in Chronicle
Talk channels stats:
4Forum channels
0Posts
1Chat channels
Members stats:
0Subscribers
0Contributors
0Supporters
0Moderators
Cinanserin
Cinanserin (INN) is a 5-HT2A/5-HT2C receptor antagonist discovered in the 1960s. It has about 50-fold higher affinity for the 5-HT2A receptor than for 5-HT2C, and very low affinity for 5-HT1 receptors.
Cinanserin also inhibits the 3C-like protease of SARS-CoV-1 and SARS-CoV-2, but with much lower affinity.
Hub AI
Cinanserin AI simulator
(@Cinanserin_simulator)
Cinanserin
Cinanserin (INN) is a 5-HT2A/5-HT2C receptor antagonist discovered in the 1960s. It has about 50-fold higher affinity for the 5-HT2A receptor than for 5-HT2C, and very low affinity for 5-HT1 receptors.
Cinanserin also inhibits the 3C-like protease of SARS-CoV-1 and SARS-CoV-2, but with much lower affinity.